Context Therapeutics Inc. (CNTX) SEC filings
CNTX SEC filings moved a median of -2.00% by the close. CNTX SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the CNTX overview →
67 measured CNTX SEC filing events.
Where these CNTX SEC filings landedvs 67 measured CNTX SEC filing reactions
| Middle 50% of CNTX SEC filing reactions | -6.72% to +0.27% |
|---|---|
| Median reaction (to close) | -2.00% |
| Measured reactions | 67 |
Point-in-time · zero look-ahead
Half of the 67 CNTX SEC filing events with a measured close landed between -6.72% and +0.27%; 30% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Context Therapeutics For: Jun 30 | SEC filing · Form 10-Q | +4.42% | -0.20% | |
| Form 8-K Context Therapeutics For: Aug 05 | SEC filing · Form 8-K | +4.42% | -0.20% | |
| Form 8-K Context Therapeutics For: Jul 29 | SEC filing · Form 8-K | -2.41% | -2.49% | |
| Form 8-K Context Therapeutics For: Jun 24 | SEC filing · Form 8-K | -2.03% | -0.81% | |
| Form 8-K Context Therapeutics For: Jun 15 | SEC filing · Form 8-K | -26.15% | -47.76% | |
| Form 8-K Context Therapeutics For: May 14 | SEC filing · Form 8-K | +0.65% | -0.92% | |
| Form 10-Q Context Therapeutics For: Mar 31 | SEC filing · Form 10-Q | -2.09% | -2.51% | |
| Form 8-K Context Therapeutics For: Apr 30 | SEC filing · Form 8-K | +3.52% | +1.32% | |
| Form ARS Context Therapeutics For: Dec 31 | SEC filing · Form ARS | -2.79% | -6.77% | |
| Form DEF 14A Context Therapeutics For: Apr 28 | SEC filing · Form DEF | -2.79% | -6.77% | |
| Form DEFA14A Context Therapeutics | SEC filing · Form DEFA14A | -2.79% | -6.77% | |
| Form PRE 14A Context Therapeutics For: Jun 24 | SEC filing · Form PRE | -1.65% | -7.00% | |
| Form 8-K Context Therapeutics For: Apr 02 | SEC filing · Form 8-K | +1.92% | +4.62% | |
| Form 10-K Context Therapeutics For: Dec 31 | SEC filing · Form 10-K | -4.88% | -3.05% | |
| Form 8-K Context Therapeutics For: Mar 23 | SEC filing · Form 8-K | -4.88% | -3.05% | |
| Form S-8 Context Therapeutics | SEC filing · Form S-8 | -4.88% | -3.05% | |
| Form 8-K Context Therapeutics For: Mar 11 | SEC filing · Form 8-K | +5.12% | -7.83% | |
| Form 8-K Context Therapeutics For: Feb 24 | SEC filing · Form 8-K | +2.83% | +4.09% | |
| Form 8-K Context Therapeutics For: Jan 08 | SEC filing · Form 8-K | -1.77% | -5.33% | |
| Form 10-Q Context Therapeutics For: Sep 30 | SEC filing · Form 10-Q | -1.35% | -3.60% | |
| Form 8-K Context Therapeutics For: Nov 05 | SEC filing · Form 8-K | -1.35% | -3.60% | |
| Form 8-K Context Therapeutics For: Oct 24 | SEC filing · Form 8-K | -0.80% | -1.60% | |
| Form 8-K Context Therapeutics For: Oct 17 | SEC filing · Form 8-K | -0.37% | -6.62% | |
| Form 8-K Context Therapeutics For: Aug 28 | SEC filing · Form 8-K | +3.53% | -0.02% | |
| Form 10-Q Context Therapeutics For: Jun 30 | SEC filing · Form 10-Q | -0.65% | -0.80% | |
| Form 8-K Context Therapeutics For: Jun 12 | SEC filing · Form 8-K | -1.24% | +0.11% | |
| Form 8-K Context Therapeutics For: Jun 02 | SEC filing · Form 8-K | -3.32% | -2.00% | |
| Form 10-Q Context Therapeutics For: Mar 31 | SEC filing · Form 10-Q | -8.95% | -8.93% | |
| Form ARS Context Therapeutics For: Dec 31 | SEC filing · Form ARS | -1.25% | +1.78% | |
| Form DEF 14A Context Therapeutics For: Jun 12 | SEC filing · Form DEF | -1.25% | +1.78% | |
| Form DEFA14A Context Therapeutics | SEC filing · Form DEFA14A | -1.25% | +1.78% | |
| Form 8-K Context Therapeutics For: Apr 09 | SEC filing · Form 8-K | -4.61% | +0.30% | |
| Form PRE 14A Context Therapeutics For: Jun 12 | SEC filing · Form PRE | +0.00% | +7.08% | |
| Form 10-K Context Therapeutics For: Dec 31 | SEC filing · Form 10-K | +3.08% | +0.23% | |
| Form S-8 Context Therapeutics | SEC filing · Form S-8 | +3.08% | +0.23% | |
| Form 8-K Context Therapeutics For: Feb 27 | SEC filing · Form 8-K | +0.00% | -7.24% | |
| Form 8-K Context Therapeutics For: Jan 14 | SEC filing · Form 8-K | -0.97% | -4.84% | |
| Form 8-K Context Therapeutics For: Jan 10 | SEC filing · Form 8-K | +0.00% | -1.91% | |
| Form 8-K Context Therapeutics For: Dec 23 | SEC filing · Form 8-K | +6.13% | -7.55% | |
| Form 8-K Context Therapeutics For: Dec 02 | SEC filing · Form 8-K | +1.97% | -0.66% | |
| Form EFFECT Context Therapeutics | SEC filing · Form EFFECT | +0.00% | +0.00% | |
| Form 10-Q Context Therapeutics For: Sep 30 | SEC filing · Form 10-Q | -1.33% | -7.11% | |
| Form S-3 Context Therapeutics | SEC filing · Form S-3 | -1.33% | -7.11% | |
| Form 8-K Context Therapeutics For: Sep 23 | SEC filing · Form 8-K | +3.22% | -7.56% | |
| Form 8-K Context Therapeutics For: Sep 17 | SEC filing · Form 8-K | +0.00% | -6.67% | |
| Form 8-K Context Therapeutics For: Sep 04 | SEC filing · Form 8-K | +4.08% | -0.82% | |
| Form 10-Q Context Therapeutics For: Jun 30 | SEC filing · Form 10-Q | -0.63% | +1.27% | |
| Form DEF 14A Context Therapeutics For: Sep 17 | SEC filing · Form DEF | -3.03% | +6.55% | |
| Form DEFA14A Context Therapeutics | SEC filing · Form DEFA14A | -3.03% | +6.55% | |
| Form PRE 14A Context Therapeutics For: Sep 17 | SEC filing · Form PRE | +0.00% | +8.91% | |
| Form 8-K Context Therapeutics For: Jul 09 | SEC filing · Form 8-K | -2.44% | -2.44% | |
| Form 8-K Context Therapeutics For: Jun 13 | SEC filing · Form 8-K | -5.30% | -0.51% | |
| Form EFFECT Context Therapeutics | SEC filing · Form EFFECT | -1.30% | +2.00% | |
| Form S-3 Context Therapeutics | SEC filing · Form S-3 | +4.15% | +6.38% | |
| Form D Context Therapeutics | SEC filing · Form D | -2.17% | +8.70% | |
| Form 10-Q Context Therapeutics For: Mar 31 | SEC filing · Form 10-Q | +0.55% | +0.55% | |
| Form 8-K Context Therapeutics For: May 01 | SEC filing · Form 8-K | +1.42% | -0.57% | |
| Form ARS Context Therapeutics For: Dec 31 | SEC filing · Form ARS | +0.00% | -2.84% | |
| Form DEF 14A Context Therapeutics For: Jun 13 | SEC filing · Form DEF | +0.00% | -2.84% | |
| Form DEFA14A Context Therapeutics | SEC filing · Form DEFA14A | +0.00% | -2.84% | |
| Form 8-K Context Therapeutics For: Apr 01 | SEC filing · Form 8-K | +4.66% | -8.67% | |
| Form 10-K Context Therapeutics For: Dec 31 | SEC filing · Form 10-K | +2.59% | -7.76% | |
| Form 8-K Context Therapeutics For: Mar 19 | SEC filing · Form 8-K | +2.59% | -7.76% | |
| Form S-8 Context Therapeutics | SEC filing · Form S-8 | +2.59% | -7.76% | |
| Form 8-K Context Therapeutics For: Feb 29 | SEC filing · Form 8-K | +0.00% | -7.08% | |
| Form 10-Q Context Therapeutics For: Sep 30 | SEC filing · Form 10-Q | — | -2.47% | |
| Form 8-K Context Therapeutics For: Oct 31 | SEC filing · Form 8-K | +0.00% | +1.92% |
Keep exploring
More CNTX: earnings → · analyst actions → · CNTX overview →